Biologic Mechanisms of Oral Cancer Pain and Implications for Clinical Therapy

Overview

Journal J Dent Res

Specialty Dentistry

Date 2011 Oct 6

PMID 21972258

Citations 50

Authors

C T Viet

B L Schmidt

Affiliations

Soon will be listed here.

Abstract

Cancer pain is an ever-present public health concern. With innovations in treatment, cancer patients are surviving longer, but uncontrollable pain creates a poor quality of life for these patients. Oral cancer is unique in that it causes intense pain at the primary site and significantly impairs speech, swallowing, and masticatory functions. We propose that oral cancer pain has underlying biologic mechanisms that are generated within the cancer microenvironment. A comprehensive understanding of key mediators that control cross-talk between the cancer and peripheral nervous system, and possible interventions, underlies effective cancer pain management. The purpose of this review is to explore the current studies on oral cancer pain and their implications in clinical management for cancer pain in general. Furthermore, we will explore the endogenous opioid systems and novel cancer pain therapeutics that target these systems, which could solve the issue of opiate tolerance and improve quality of life in oral cancer patients.

Citing Articles

Pain Management in Animals with Oncological Disease: Opioids as Influencers of Immune and Tumor Cellular Balance.

Pinheiro A, Petrucci G, Dourado A, Silva F, Pires I Cancers (Basel). 2024; 16(17).

PMID: 39272873 PMC: 11394036. DOI: 10.3390/cancers16173015.

Phytochemical Targeting of Nerve Growth Factor by Thymoquinone and Cuscutin: A Molecular Dynamics Simulation Study.

Begum N, Ramadoss R, Yadalam P, Ramani P, Ramalingam K Cureus. 2024; 16(7):e63727.

PMID: 39099944 PMC: 11296693. DOI: 10.7759/cureus.63727.

Nociceptive adenosine A receptor on trigeminal nerves orchestrates CGRP release to regulate the progression of oral squamous cell carcinoma.

Jiang L, Zhou Y, Tang S, Yang D, Zhang Y, Zhang J Int J Oral Sci. 2024; 16(1):46.

PMID: 38886342 PMC: 11183250. DOI: 10.1038/s41368-024-00308-w.

Stimulator of Interferon Genes Pathway Activation through the Controlled Release of STINGel Mediates Analgesia and Anti-Cancer Effects in Oral Squamous Cell Carcinoma.

Dong M, Dharmaraj N, Kaminagakura E, Xue J, Leach D, Hartgerink J Biomedicines. 2024; 12(4).

PMID: 38672274 PMC: 11047833. DOI: 10.3390/biomedicines12040920.

Temporal characterization of acute pain and toxicity kinetics during radiation therapy for head and neck cancer. A retrospective study.

Salama V, Youssef S, Xu T, Wahid K, Chen J, Rigert J Oral Oncol Rep. 2024; 7.

PMID: 38638130 PMC: 11025722. DOI: 10.1016/j.oor.2023.100092.

References

Khodorova A, Navarro B, Jouaville L, Murphy J, Rice F, Mazurkiewicz J . Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med. 2003; 9(8):1055-61. DOI: 10.1038/nm885. View

Ibrahim M, Porreca F, Lai J, Albrecht P, Rice F, Khodorova A . CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A. 2005; 102(8):3093-8. PMC: 549497. DOI: 10.1073/pnas.0409888102. View

Pert C, Snyder S . Opiate receptor: demonstration in nervous tissue. Science. 1973; 179(4077):1011-4. DOI: 10.1126/science.179.4077.1011. View

Goss J, Harley C, Mata M, OMalley M, Goins W, Hu X . Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol. 2002; 52(5):662-5. DOI: 10.1002/ana.10343. View

Goss J, Mata M, Goins W, Wu H, Glorioso J, Fink D . Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 2001; 8(7):551-6. DOI: 10.1038/sj.gt.3301430. View

Fischer D, Villines D, Kim Y, Epstein J, Wilkie D . Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. 2009; 18(7):801-10. PMC: 3682075. DOI: 10.1007/s00520-009-0712-5. View

RIGOR Sr B . Pelvic cancer pain. J Surg Oncol. 2001; 75(4):280-300. DOI: 10.1002/1096-9098(200012)75:4<280::aid-jso13>3.0.co;2-q. View

Lam D, Schmidt B . Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway. Pain. 2010; 149(2):263-272. PMC: 2861734. DOI: 10.1016/j.pain.2010.02.010. View

BRAZ J, Beaufour C, Coutaux A, Epstein A, Cesselin F, Hamon M . Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci. 2001; 21(20):7881-8. PMC: 6763863. View

10.

Pickering V, Jordan R, Schmidt B . Elevated salivary endothelin levels in oral cancer patients--a pilot study. Oral Oncol. 2006; 43(1):37-41. DOI: 10.1016/j.oraloncology.2005.12.027. View

11.

Wolfe D, Mata M, Fink D . A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther. 2009; 16(4):455-60. PMC: 2683467. DOI: 10.1038/gt.2009.17. View

12.

Mague S, Isiegas C, Huang P, Liu-Chen L, Lerman C, Blendy J . Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci U S A. 2009; 106(26):10847-52. PMC: 2705603. DOI: 10.1073/pnas.0901800106. View

13.

Saghafi N, Lam D, Schmidt B . Cannabinoids attenuate cancer pain and proliferation in a mouse model. Neurosci Lett. 2010; 488(3):247-51. PMC: 3099480. DOI: 10.1016/j.neulet.2010.11.039. View

14.

Di Maio M, Gridelli C, Gallo C, Manzione L, Brancaccio L, Barbera S . Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer. 2004; 90(12):2288-96. PMC: 2409536. DOI: 10.1038/sj.bjc.6601810. View

15.

He Y, Yang C, Kirkmire C, Wang Z . Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J Neurosci. 2010; 30(30):10251-8. PMC: 2943348. DOI: 10.1523/JNEUROSCI.2419-10.2010. View

16.

Wu W, Wang Y, Fang Y, Zhou H . Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery. Mol Diagn Ther. 2009; 13(5):331-7. DOI: 10.1007/BF03256337. View

17.

Nyberg P, Ylipalosaari M, Sorsa T, Salo T . Trypsins and their role in carcinoma growth. Exp Cell Res. 2006; 312(8):1219-28. DOI: 10.1016/j.yexcr.2005.12.024. View

18.

Hans G, Deseure K, Robert D, De Hert S . Neurosensory changes in a human model of endothelin-1 induced pain: a behavioral study. Neurosci Lett. 2007; 418(2):117-21. DOI: 10.1016/j.neulet.2007.03.008. View

19.

Mercadante S, Fulfaro F, Casuccio A . A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer. 2002; 38(10):1358-63. DOI: 10.1016/s0959-8049(02)00102-8. View

20.

Oertel B, Kettner M, Scholich K, Renne C, Roskam B, Geisslinger G . A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem. 2009; 284(10):6530-5. DOI: 10.1074/jbc.M807030200. View